Tech Company Financing Transactions

PreciseDx Funding Round

On 6/19/2025, PreciseDx secured $11 million in financing from Eventide Asset Management, Merck Global Health Innovation Fund and Philips Venture Capital Fund.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Artificial Intelligence

Mailing Address

1111 Amsterdam Stuyvesant Building 8-822
New York, NY 10025
USA

Phone

(646) 818-9330

Website

www.precisedx.ai

Email Address

[email protected]

Overview

Our mission is to democratize access to high-quality medical care and information, regardless of the institution or its geographical location. PreciseDx augments current oncology diagnostics and provides an objective review of each patient's risk, eliminating any subjectivity in the review of patient results.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chairman

Carlos Cordon-Cardo

        

Chief Executive Officer

Wayne Brinster

        

Chief Medical Officer

Michael Donovan

        

Chief Scientific Officer

Gerardo Fernandez

        

Chief Technical Officer

Jack Zeineh

        

VP - Finance

Andrew Borsanyi

        

Browse more venture capital transactions:

Prev: 6/19/2025: Brightspeed venture capital transaction
Next: 6/19/2025: Infinity Bio venture capital transaction

Share this article

Where The Data Comes From

We do our best to record every notable VC transaction. VC transactions reported here come from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary